LSV Asset Management’s Puma Biotechnology PBYI Stock Holding History

LSV Asset Management’s Portfolio PBYI Stock Details PBYI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$13.1M	Buy	1,617,981 +435,113	+37%	+$3.19M	0.02%	399
2026 Q1	$7.56M	Buy	1,182,868 +778,066	+192%	+$5.02M	0.02%	425
2025 Q4	$2.41M	Sell	404,802 -155,119	-28%	-$824K	0.01%	564
2025 Q3	$2.97M	Buy	559,921 +24,181	+5%	+$103K	0.01%	532
2025 Q2	$1.84M	Buy	535,740 +482,340	+903%	+$1.54M	﹤0.01%	563
2025 Q1	$158K	Hold	53,400	–	–	﹤0.01%	762
2024 Q4	$163K	Buy	53,400 +23,000	+76%	+$66.9K	﹤0.01%	768
2024 Q3	$78K	Hold	30,400	–	–	﹤0.01%	804
2024 Q2	$99K	Hold	30,400	–	–	﹤0.01%	823
2024 Q1	$161K	Sell	30,400 -56,251	-65%	-$303K	﹤0.01%	810
2023 Q4	$375K	Hold	86,651	–	–	﹤0.01%	761
2023 Q3	$228K	Sell	86,651 -107,900	-55%	-$367K	﹤0.01%	792
2023 Q2	$687K	Hold	194,551	–	–	﹤0.01%	729
2023 Q1	$601K	Sell	194,551 -6,600	-3%	-$24.9K	﹤0.01%	706
2022 Q4	$851K	Buy	201,151 +19,052	+10%	+$65.7K	﹤0.01%	668
2022 Q3	$432K	Buy	+182,099	New	+$532K	﹤0.01%	730

Other funds holding PBYI

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

RWM

Ritholtz Wealth Management New York $6.7B AUM 32.7% 1-Year Est. Return

Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

State Board of Administration of Florida Retirement System Tallahassee, Florida $60.3B AUM 42.74% 1-Year Est. Return

Russell Investments Group London, United Kingdom $114B AUM 41.71% 1-Year Est. Return

PAM

Panagora Asset Management Boston, Massachusetts $32.6B AUM 52.29% 1-Year Est. Return

PFS

Prospera Financial Services Dallas, Texas $6.89B AUM 37.41% 1-Year Est. Return

Haven Private Orlando, Florida $263M AUM 21.06% 1-Year Est. Return

STRS Ohio Columbus, Ohio $26.7B AUM 43.32% 1-Year Est. Return

LSV Asset Management's PBYI Position: Q2 2026 in Review

LSV Asset Management increased its Puma Biotechnology (PBYI) stake by 37% in Q2 2026, buying an estimated $3.19M and bringing the position to 1,617,981 shares worth $13.1M. The position accounts for 0.02% of the portfolio, ranked #399.

LSV Asset Management first reported a position in PBYI in Q3 2022 and has held it in 16 quarters since. 72 funds tracked by Wall St. Rank hold PBYI as of Q2 2026.

LSV Asset Management held 1,617,981 shares of Puma Biotechnology worth $13.1M as of Q2 2026.
LSV Asset Management bought 435,113 Puma Biotechnology shares in Q2 2026, an estimated $3.19M.
Puma Biotechnology made up 0.02% of LSV Asset Management's portfolio in Q2 2026, its #399 holding.
LSV Asset Management first reported a position in Puma Biotechnology in Q3 2022 and has held it in 16 quarters since.
72 funds tracked by Wall St. Rank held Puma Biotechnology as of Q2 2026.

Based on LSV Asset Management's 13F filing for Q2 2026, filed 6 Aug 2026.